Purchase Order 75D30124P19616
Award Date 9/13/24
Potential Completion Date 11/1/24
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Definitive Contract to Bioivt, LLC, a for-profit limited liability company, to provide COVID-19 positive blood serum. The Firm Fixed Price contract, valued at $370,350.00, has a completion date of April 28, 2021. Bioivt, LLC is a leading global provider of high-quality biological specimens and has previously supported various medical research programs across federal agencies, including the Defense...
- This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Bioivt, LLC, a leading global provider of high-quality biological specimens and related services. The $71,960 Firm Fixed Price Purchase Order is for the delivery of Serum for OROV (Oropouche virus) Response, with a period of performance through September 30, 2024. Bioivt has previously supported medical research and diagnostic testing for military readiness and medical countermeasure development...
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Bioivt, LLC, a leading global provider of biological specimens and services. The $15,450.00 contract is for the delivery of human cerebrospinal fluid frozen samples by May 30, 2025. Bioivt, a for-profit limited liability company, has a strong track record of providing biological materials to support medical research programs across federal agencies including NIAID,...
- This firm fixed-price purchase order was awarded to Bioivt, LLC by the National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services. The $18,575 contract is for the delivery of AD HUMAN CSF and has a period of performance through November 8, 2024. Bioivt is a leading global provider of biological specimens and value-added services, and has previously supported medical research programs across various federal agencies through prime...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $490.9 million cost-plus-fixed-fee definitive contract to American Type Culture Collection (ATCC) for the International Reagent Resource (IRR) program, effective March 1, 2019, with a completion date of February 28, 2029. ATCC, a nonprofit biological resource center headquartered in Manassas, Virginia, will serve as the prime contractor for this effort supporting CDC's disease surveillance and response capabilities. The...
- The Department of Health and Human Services Centers for Disease Control and Prevention (HHS-CDC) in Pittsburgh awarded a $19,036 purchase order to Inbios International Inc. of Seattle, Washington for INBIOS supplies and reagents. As a prime contractor, Inbios will provide laboratory materials to support HHS-CDC's disease prevention and control efforts. The firm fixed price contract runs from August 24, 2023 through September 28, 2023 at the Inbios location in Seattle. No subcontractors or set...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $20,880 purchase order to VWR International LLC for the delivery of QSCRIPT XLT 1-ST TM L-ROX 500R. As the prime contractor, VWR International will provide the requested products to the CDC under a firm fixed price contract running from September 20th through October 20th of 2023. The CDC works to protect public health and safety through the control and prevention of disease, injury,...
- Bio-Rad Laboratories Inc. received a $33,000 firm fixed price purchase order award from the Centers for Disease Control and Prevention (CDC) Pittsburgh, effective August 7, 2024, with an ultimate completion date of April 22, 2025. The contract covers FDA-approved test kits, readers, and laptops from Bio-Rad to be used for validating and ensuring quality assurance of sample testing. These diagnostic tools are intended to strengthen rapid test quality assurance capabilities in international...
- The Centers for Disease Control and Prevention (CDC) awarded a $6,723 purchase order to Inotiv, Inc. for pathology evaluation services. Under this firm fixed price contract, Inotiv will provide unspecified pathology evaluation services to the CDC from its facility in Morgantown, West Virginia between July 2023 and July 2024. As the prime contractor, Inotiv will perform the contracted services without the use of major subcontractors. No set aside designation or associated multi-award contract...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a firm fixed-price purchase order to Biomerieux Inc. on July 24, 2024, with a ceiling value of $11,973.13. The contract covers NucliSens reagents designed for use on Biomerieux's sample extraction platforms—specifically the NucliSens EasyMAG, eMAG, and MiniMAG systems—which have been validated for HIV drug resistance testing. These reagents support the Molecular Diagnostic and Surveillance Team's surveillance operations at...